IRIS
CIOTTA, Liliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.512
EU - Europa 1.177
AS - Asia 1.160
AF - Africa 221
SA - Sud America 209
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 6.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.380
SG - Singapore 516
CN - Cina 493
IE - Irlanda 309
UA - Ucraina 307
IT - Italia 213
BR - Brasile 194
CA - Canada 117
CI - Costa d'Avorio 114
RU - Federazione Russa 104
SN - Senegal 90
DE - Germania 67
SE - Svezia 59
KR - Corea 46
VN - Vietnam 27
GB - Regno Unito 23
CH - Svizzera 20
FR - Francia 16
UZ - Uzbekistan 16
IN - India 14
AT - Austria 13
BD - Bangladesh 8
MX - Messico 8
NL - Olanda 8
ZA - Sudafrica 8
FI - Finlandia 7
PL - Polonia 7
AR - Argentina 6
ES - Italia 6
JP - Giappone 5
TR - Turchia 5
EU - Europa 4
GR - Grecia 4
JO - Giordania 4
PK - Pakistan 4
TN - Tunisia 4
BE - Belgio 3
DZ - Algeria 3
EC - Ecuador 3
IQ - Iraq 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
ID - Indonesia 2
JM - Giamaica 2
LB - Libano 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
VE - Venezuela 2
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
PW - Palau 1
TJ - Tagikistan 1
TV - Tuvalu 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 6.285
Salva come PNG Salva come JPEG
Città #
Santa Clara 664
Dallas 561
Singapore 347
Jacksonville 345
Dublin 306
Ashburn 294
Chandler 292
Chicago 154
Boardman 141
Abidjan 114
Nanjing 92
Dakar 90
Cambridge 88
Lawrence 87
Toronto 87
Andover 83
Beijing 77
Hefei 59
Civitanova Marche 51
San Mateo 50
Nanchang 44
Des Moines 41
Wilmington 39
Los Angeles 36
Bremen 32
Hebei 28
Seoul 27
Tianjin 27
Changsha 24
Saint Petersburg 24
Shenyang 24
Ottawa 19
São Paulo 19
Jiaxing 18
Seongnam 17
Taormina 16
Munich 15
Council Bluffs 14
Moscow 13
Catania 9
New York 9
Rome 9
Tashkent 9
Hanoi 8
Jinan 8
Seattle 8
Milan 7
The Dalles 7
Brooklyn 6
Columbus 6
Helsinki 6
Naples 6
Ningbo 6
Zhengzhou 6
Ann Arbor 5
Campinas 5
Den Haag 5
Hangzhou 5
Ho Chi Minh City 5
Norwalk 5
Tokyo 5
Amman 4
Belo Horizonte 4
Brasília 4
Charlotte 4
Curitiba 4
Dong Ket 4
Durban 4
Frankfurt Am Main 4
Kunming 4
Montreal 4
Phoenix 4
Pune 4
Warsaw 4
Bari 3
Blumenau 3
Brussels 3
Caxias do Sul 3
Lausanne 3
Palermo 3
Rio de Janeiro 3
San Francisco 3
San Giovanni la Punta 3
Scafa 3
Stockholm 3
São José do Rio Preto 3
Turin 3
Vienna 3
Amantea 2
Ankara 2
Assago 2
Avola 2
Baghdad 2
Bologna 2
Boston 2
Boydton 2
Calgary 2
Campo Largo 2
Catanduva 2
Cologno Al Serio 2
Totale 4.722
Salva come PNG Salva come JPEG
Nome #
Intracesarean removal of two huge fibroids occupying the whole uterine fundus: A case report 299
A specific application of locus of control of behaviour scale on patients with pelvic floor alteration 117
EFFICACIA CLINICA DELLA N-OLEIL-FOSFATIDIL-ETANOLAMINA (NOPE) NELLA TERAPIA DELL’OBESITA’: NOSTRA ESPERIENZA 115
D-Chiro-Inositol treatment in patients with polycystic ovary syndrome 112
Acetyl-L-Carnitine in the treatment of patients with weight-loss related to hypothalamic amenorrhea 111
Adolescents and PCOS: Last update on diagnosis and therapy 107
Effects of Myo-Inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial 102
Hydronephrosis and utero-vaginal prolapse in postmenopausal women: management and treatment 100
Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 99
ASPETTI PSICHICI DELLA SINDROME PREMESTRUALE (PMS) E DISTURBO DISFORICO DELLA FASE LUTEALE (PMDD): NUOVE PROSPETTIVE TERAPEUTICHE, IL VITEX AGNUS CASTUS (VAC) : NOSTRE ESPERIENZE 97
Contraccezione orale con estro-progestinici e sviluppo di mastopatie benigne 95
Clinical and endocrine effects of finasteride, a 5a-reductase inhibitor, in women with idiopathic hirsutism 94
Protection of ovarian tissue from radiotherapy 91
L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history 89
PCOS treatment with an oral contraceptive containing Drospirenone, alone or in association with D-Chiro-Inositol 88
Diabete in Gravidanza: Focus sulle Complicanze 88
Terapia ormonale sostitutiva: effetti sull’endometrio in donne a rischio di adenocarcinoma endometriale 87
Clinical affects of finasteride , 5-a-reductase inhibitor in post menopausal women with hair loss 87
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease 86
B19 Parvovirus non-immune hydrops fetalis: a case report. 84
Clomiphene citrate and dydrogesterone: a combined therapy for functional hypothalamic amenorrhea 84
Correlation between thyroid function and post-partum depression: preliminary dates on sample study 83
Adrenal steroid secretion in postmenopausal women during raloxifene therapy 83
Effects of inositol on oocytes’ quality in patients with polycystic ovary syndrome 83
The reproduction in women affected by cooley disease 83
Screening for preeclampsia by uterine artery Doppler velocimetry in the late first trimester of pregnancy 78
Myo-inositol vs D-Chiro-Inositol in PCOS treatment 78
TERAPIA DEL DIABETE GESTAZIONALE: GLI ATTUALI APPROCCI 78
Iter diagnostico e terapeutico delle amenorre 76
Studio prospettivo sulla riparazione del cistocele con allografts in derma porcino tipo Pelvisoft (Bard Urological) 76
Aspetti metabolici ed epatici della policistosi ovarica 75
Laparoscopic removal of a giant paratubal cyst complicated by hydronephrosis 74
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 74
Effects of genisteina and daidzeina in climateric symptoms and postmenopausal bone loss 73
The efficacy of a pollen extract as non estrogenic alternative to hormone replacement therapy in symptomatic perimenopausal women 71
Assisted reproduction in women affected by endometriosis: Our experience [Procreazione medicalmente assistita nelle pazienti affette da endometriosi: La nostra esperienza] 70
Influence of sport and low animal saturated fats intake diet on lipid dismetabolisms in postmenopausal women 68
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 65
Male equivalent polycystic ovarian syndrome: Hormonal, metabolic and clinical aspects 65
Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia 64
Original study: role of BMP-15 in the pathogenesis of premature ovarian failure (POF) 63
Effetti del trattamento con metaformina sulla distribuzione corporea dell'adipe, sul profilo lipidico e sulla risposta insulinemica in donne affette da sindrome dell'ovaio policistico 62
Uterine bleeding pattern during low dosage Noretisterone acetate and 17-b-Estradiol treatment in postmenopausal patients 62
Oral Contraception and Breast Diseases. 61
Oral contraception and benign breast disease 60
Efficacia dell’a-tocoferolo acetato (100% vitamina E) per via vaginale nella prevenzione delle erosioni dopo riparazione protesica del prolasso urogenitale 60
EFFETTI CLINICI DEL TRATTAMENTO CON FITOESTROGENI IN DONNE IN POST-MENOPAUSA 59
Tolleranza clinica e metabolica del trattamento long-term con alendronato (70 mg) 59
Efficacia e sicurezza del nuovo contraccettivo orale antiandrogeno contenente Clormadinone Acetato (Belaro) follow up a 12 mesi 59
Medical therapy for endometriosis: a literature review. 59
Trattamento topico dell’irsutismo facciale con eflornitina in donne in post-menopausa 58
Pseudoachantosis nigricans: a skin maker for hyperinulinemia 57
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients 57
Influence of HRT on body mass index, arterial pressure profile and lipidic metabolism in postmenopausal women 56
Problematiche terapeutiche in donne affette da POF (premature ovarian faiilure) 56
Fisiologia delle amenoree 56
Effetti della genisteina e daidzeina sui sintomi climaterici e sulla perdita ossea in donne in postmenopausa 56
Efficacy of Cimicifuga Racemosa on Menopausal Symptoms in Women with Breast Cancer 55
Weight change and adverse event incidence with a different combined estradiol-progestin regimens in postmenopausal women 55
Innovative genetic, clinical and endocrinological aspects in young females affected with premature ovarian insufficiency 55
Risultati clinici e metabolici durante il trattamento con Alendronato con somministrazione settimanale 54
Effetti sul metabolismo lipidico e sui parametri emocoagulativi della terapia con raloxifene in donne osteoporotiche in postmenopausa 54
Metabolismo osseo in donne in postmenopausa in trattamento con fitoestrogeni 54
Effetti della terapia con metformina in pazienti obese con PCOS 54
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 54
Effetti del Myo-inositolo sulla qualità ovocitaria in pazienti affette da Sindrome dell’Ovaio Policistico 54
Induction of ovulation in thalassemic patients 53
Evaluation of thyroid function at delivery and in the first 6 months postpartum: preliminary data in a Sicilian Sample study 53
Low birth-weight is a PCOS risk factor for Southern-Italian women 52
Hydronephrosis due to voluminous adnexial mass in a teenager: management and treatment 52
Incidenza di eventi avversi durante terapia con dose monosettimanale (70 mg) o giornaliera (10 mg) di alendronato in donne osteopeniche in postmenopausa 52
Procreazione Medicalmente Assistita ed Endometriosi 52
Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease 52
ISOLATED ELEVATED LIVER ENZYME AT 28°WEEK OF GESTATION: A CASE REPORT 51
Trattamento con Gn-RH analogo per la protezione del potenziale riproduttivo in giovani donne affette da linfoma di Hodking e non Hodking 51
Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women 51
Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome [Effetti dell'inositolo sulla qualità ovocitaria in pazienti affette da sindrome dell'ovaio policistico] 50
Subclinical hypothyroidism among subjective and objective symptoms in menopause transition: prevalence and incidence 50
Therapetic strategies in women affected by premature ovarian failure 50
Patologia mammaria benigna e gravidanza 50
Effetti della genisteina sulla perdita ossea in donne in post menopausa 49
Trattamento "long-term" con dosi ridotte di flutamide nella prevenzione della recidive sitomatologiche in pazieti con PCOS 48
Monoprotesi per il trattamento simultaneo del cistocele e dell’incontinenza urinaria da stress (protocollo NAZCA): studio prospettico 47
Role of DEXA and ultrasonometry in the evaluation of osteoporotic risk in postmenopausal women 47
Relationship between tumour necrosis factor alpha and sex steroid concentrations in the follicular fluid of women with immunological infertility 46
Fertility after multiple myomectomy 44
Metabolic Aspects of PCOS Treatment with Insulin Sensitizers 44
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 2008 44
Long-term treatement with low-dose flutamide in the syntomatic relapses prevention of patient suffering from PCOS 41
Il carcinoma mammario e gravidanza 39
Problematiche terapeutiche in donne affette da POF (premature ovarian failure) 38
Genetics pathogenesis in the ovarian insufficiency 36
Totale 6.380
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021387 0 0 0 1 150 11 60 2 51 2 80 30
2021/2022623 86 91 4 10 95 1 84 23 68 0 27 134
2022/2023989 90 55 12 101 80 166 2 205 243 6 19 10
2023/2024561 19 58 9 32 19 60 1 246 0 5 65 47
2024/20251.798 14 293 96 62 505 286 6 42 109 148 92 145
2025/20261.106 247 165 645 49 0 0 0 0 0 0 0 0
Totale 6.380